兴齐眼药: 沈阳兴齐眼药股份有限公向特定对象发行股票募集资金使用可行性分析报告

Fundraising Plan - The company plans to raise a total of no more than 850 million yuan, with the net amount after deducting issuance costs to be used entirely for project construction [1] - The total investment for the projects exceeds the net amount raised, with the company planning to cover the shortfall through self-funding or other financing methods [1] Necessity and Feasibility of Fundraising - The R&D center construction project is a continuation of a previous fundraising initiative, aimed at addressing a funding gap to ensure smooth project development [2][3] - The project aims to establish a comprehensive R&D headquarters with international vision, focusing on intelligent, digital, and international research capabilities [2] Project Details - The total investment for the R&D center is 984.23 million yuan, with 207.97 million yuan already invested from previous fundraising efforts and 650 million yuan planned from the current fundraising [3][4] - The project will include advanced facilities such as a high-standard data center and automated systems to enhance research efficiency and data reliability [3] R&D Focus and Market Position - The company emphasizes the importance of R&D as a core driver for pharmaceutical development, with a focus on building a strong pipeline of innovative products [5][6] - Recent product launches, including a treatment for dry eye syndrome, have significantly contributed to revenue growth, with total revenue increasing from approximately 689 million yuan in 2020 to about 1.943 billion yuan in 2024 [5][6] Future R&D Directions - The company is expanding its product line in the ophthalmology sector, focusing on innovative treatments for various eye diseases, including age-related macular degeneration and diabetic macular edema [7][8] - The development of new treatment methods, including gene therapy, is seen as a key opportunity for the company to enhance its market position [7] Financial Impact of Fundraising - The fundraising will improve the company's liquidity and capital structure, enhancing its ability to manage risks and support sustainable growth [12][13] - The successful implementation of the fundraising projects is expected to strengthen the company's core competitiveness and long-term viability [13]